From the lab to the market: regulations and development of new treatments.

Translating research ideas into prescription medicines is a long journey [...]

By |2020-09-30T07:47:26+00:00September 30th, 2020|Consortium, Inflammatory bowel diseases, Nanomedicine, Nanotherapy, New Deal|

COVID-19 and Inflammatory Bowel Disease: an insight into the relationship between conditions

In December 2019 the now named severe acute respiratory syndrome [...]

By |2020-08-26T10:19:24+00:00August 26th, 2020|Inflammatory bowel diseases, Nanomedicine, Nanotherapy, New Deal|
Go to Top